Details for New Drug Application (NDA): 209919
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 209919
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Alembic |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209919
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 209919
Suppliers and Packaging for NDA: 209919
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209919 | ANDA | Alembic Pharmaceuticals Inc. | 62332-501 | 62332-501-05 | 1 BOTTLE, PLASTIC in 1 CARTON (62332-501-05) / 5 mL in 1 BOTTLE, PLASTIC |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209919 | ANDA | Alembic Pharmaceuticals Inc. | 62332-709 | 62332-709-05 | 1 BOTTLE in 1 CARTON (62332-709-05) / 5 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.1% BASE | ||||
Approval Date: | Dec 7, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription